Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

CD8 and CD4 T cells in west nile virus immunity and pathogenesis.

Netland J, Bevan MJ.

Viruses. 2013 Oct 22;5(10):2573-84. doi: 10.3390/v5102573. Review.

2.

CD8(+) T cell-mediated immune responses in West Nile virus (Sarafend strain) encephalitis are independent of gamma interferon.

Wang Y, Lobigs M, Lee E, Koskinen A, Müllbacher A.

J Gen Virol. 2006 Dec;87(Pt 12):3599-609.

PMID:
17098975
3.

CD8+ T cells use TRAIL to restrict West Nile virus pathogenesis by controlling infection in neurons.

Shrestha B, Pinto AK, Green S, Bosch I, Diamond MS.

J Virol. 2012 Sep;86(17):8937-48. doi: 10.1128/JVI.00673-12.

4.

Key role of T cell defects in age-related vulnerability to West Nile virus.

Brien JD, Uhrlaub JL, Hirsch A, Wiley CA, Nikolich-Zugich J.

J Exp Med. 2009 Nov 23;206(12):2735-45. doi: 10.1084/jem.20090222.

5.

CD8+ T cells mediate recovery and immunopathology in West Nile virus encephalitis.

Wang Y, Lobigs M, Lee E, Müllbacher A.

J Virol. 2003 Dec;77(24):13323-34.

6.
7.

Gamma delta T cells facilitate adaptive immunity against West Nile virus infection in mice.

Wang T, Gao Y, Scully E, Davis CT, Anderson JF, Welte T, Ledizet M, Koski R, Madri JA, Barrett A, Yin Z, Craft J, Fikrig E.

J Immunol. 2006 Aug 1;177(3):1825-32.

8.

A role for the chemokine RANTES in regulating CD8 T cell responses during chronic viral infection.

Crawford A, Angelosanto JM, Nadwodny KL, Blackburn SD, Wherry EJ.

PLoS Pathog. 2011 Jul;7(7):e1002098. doi: 10.1371/journal.ppat.1002098.

9.
10.

Interferon regulatory factor-1 (IRF-1) shapes both innate and CD8(+) T cell immune responses against West Nile virus infection.

Brien JD, Daffis S, Lazear HM, Cho H, Suthar MS, Gale M Jr, Diamond MS.

PLoS Pathog. 2011 Sep;7(9):e1002230. doi: 10.1371/journal.ppat.1002230.

11.

A recombinant influenza A virus expressing domain III of West Nile virus induces protective immune responses against influenza and West Nile virus.

Martina BE, van den Doel P, Koraka P, van Amerongen G, Spohn G, Haagmans BL, Provacia LB, Osterhaus AD, Rimmelzwaan GF.

PLoS One. 2011 Apr 26;6(4):e18995. doi: 10.1371/journal.pone.0018995.

12.

Comprehensive analysis of west nile virus-specific T cell responses in humans.

Lanteri MC, Heitman JW, Owen RE, Busch T, Gefter N, Kiely N, Kamel HT, Tobler LH, Busch MP, Norris PJ.

J Infect Dis. 2008 May 1;197(9):1296-306. doi: 10.1086/586898.

PMID:
18422442
13.

Increased frequency of Tim-3 expressing T cells is associated with symptomatic West Nile virus infection.

Lanteri MC, Diamond MS, Law JP, Chew GM, Wu S, Inglis HC, Wong D, Busch MP, Norris PJ, Ndhlovu LC.

PLoS One. 2014 Mar 18;9(3):e92134. doi: 10.1371/journal.pone.0092134.

14.

Regulatory T cells shape the resident memory T cell response to virus infection in the tissues.

Graham JB, Da Costa A, Lund JM.

J Immunol. 2014 Jan 15;192(2):683-90. doi: 10.4049/jimmunol.1202153.

15.

Role of γδ T cells in West Nile virus-induced encephalitis: friend or foe?

Wang T.

J Neuroimmunol. 2011 Dec 15;240-241:22-7. doi: 10.1016/j.jneuroim.2011.10.004. Review.

16.

Persistence of virus-specific immune responses in the central nervous system of mice after West Nile virus infection.

Stewart BS, Demarest VL, Wong SJ, Green S, Bernard KA.

BMC Immunol. 2011 Jan 20;12:6. doi: 10.1186/1471-2172-12-6.

17.

Tumor necrosis factor alpha protects against lethal West Nile virus infection by promoting trafficking of mononuclear leukocytes into the central nervous system.

Shrestha B, Zhang B, Purtha WE, Klein RS, Diamond MS.

J Virol. 2008 Sep;82(18):8956-64. doi: 10.1128/JVI.01118-08.

18.
19.

Vγ4+ T cells regulate host immune response to West Nile virus infection.

Welte T, Aronson J, Gong B, Rachamallu A, Mendell N, Tesh R, Paessler S, Born WK, O'Brien RL, Wang T.

FEMS Immunol Med Microbiol. 2011 Nov;63(2):183-92. doi: 10.1111/j.1574-695X.2011.00840.x.

20.

Role of natural killer and Gamma-delta T cells in West Nile virus infection.

Wang T, Welte T.

Viruses. 2013 Sep 20;5(9):2298-310. doi: 10.3390/v5092298. Review.

Supplemental Content

Support Center